Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

Equities

301093

CNE100004YH2

Tires & Rubber Products

End-of-day quote Shenzhen S.E. 18:00:00 2024-05-13 EDT 5-day change 1st Jan Change
22.75 CNY +0.62% Intraday chart for Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. -2.74% -29.57%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023. CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback announced on June 6, 2023 has closed with 6,412,625 shares, representing 4.81% for CNY 199.59 million. CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023. CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023. CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023 CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 26, 2023. CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves Cash Dividend for the Year 2022 CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Proposes Final Cash Dividend for 2022 CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chongqing Fuling Sanhai Lanling Co., Ltd. announced that it expects to receive CNY 576.3965 million in funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 07 June 2022 CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Approves Cash Dividend for 2021 CI
Jiangsu Hualan New Pharma to List 1.8 Million Shares Post IPO Lock-Up Period MT
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces Profit Distribution Proposal for 2021 CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces Executive Changes CI
Chart Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
More charts
Jiangsu Hualan New Pharmaceutical Material Co Ltd is a China-based company primarily engaged in the research, development, production and sales of packaging materials for direct contact injection drugs. The Company’s main products include various kinds of coated rubber stoppers, conventional rubber stoppers and others. The Company's products are mainly used in the field of pharmaceutical preparations such as infusion, freeze-drying, powder injection, monoclonal antibodies, small water injections, blood sampling, and Chinese medicine compound preparations, among others. The Company also produces plastic infusion container assemblies and urinary anorectal minimally invasive surgical instruments. The Company distributes its products within the domestic market and to overseas markets, including Italy, Egypt, Saudi Arabia, Qatar and other areas.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.61 CNY
Average target price
43.78 CNY
Spread / Average Target
+93.63%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301093 Stock
  4. News Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
  5. Jiangsu Hualan New Pharma to List 1.8 Million Shares Post IPO Lock-Up Period
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW